Real World Evidence On Demand Training
This On-Demand Training Short Course will provide an overview of how real-world evidence is being used today for evidence generation in major markets. The primary focus is evidence generation for regulatory use, with a particular focus on comparative effectiveness, but the approaches described here are useful for health technology assessments for payers. Following the major points identified by the FDA in the Frameworks document released in December, 2019, we will explain how the fitness of evidence from real-world data are assessed for any use case, key elements of design and analysis, and the current status of FDA guidance on when real-world studies will be sufficient to meet regulatory evidence requirements. Although much of the focus will be on the FDA, the course will also include an update of recent activities by the EMA regarding use of real-world (big) data.
This on-demand training course takes an average of 3.25 hours to complete. Learners have access to the course for six months from the date of purchase.
What you will learn
- Evolving regulatory landscape
- Evolving types of real-world data, uses, and ways to understand if they are fit for purpose
- Methodologic rigor including the opportunities for external comparators
- Integrated evidence
Who should attend?
At the conclusion of this course, participants should be able to:
- Describe key epidemiological design principles central to interpreting the quality and validity of real world evidence (RWE) studies;
- Apply these learnings by evaluating and discussing case presentations focused on CV safety assessments;
- Recognize when RWE based approaches are of sufficient quality to enable decision making.